Serum leptin concentrations are increased in patients with obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease, whereas serum adiponectin concentrations are decreased in these disorders. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.